So AZN for the UK, Novartis for central Europe, Bayer for Germany...
Basically, you are suggesting a type of consortium. JT chose a partner
for Canada that had no sales force...hope he don't do that again. LOL.
My problem with partnerships is they don't work. (JT selected a real
winner for his US partner.) The best solution is one owner...maybe
Roche, Novartis, or Johnson & Johnson. That way one company controls
everything Now, once a BP owns AMRN perhaps they will decide to
partner out certain jurisdictions. AMRN needs to have a competent
owner. The sooner the better.
Market Data 
Markets 
AI
